| B1 N = 123 (32.5) | B2 N = 225 (59.5) | B3 N = 30 (8.0) |
---|---|---|---|
Age (years) | 70 (45–93) | 70 (26–93) | 68 (50–86) |
Sex | |||
 Male | 104 (84.5) | 175 (77.8) | 22 (73.3) |
 Female | 19 (15.5) | 50 (22.2) | 8 (26.7) |
HBV positive | 16 (13.1) | 40 (17.8) | 6 (20.7) |
HCV positive | 81 (65.8) | 105 (46.7) | 12 (42.9) |
Plt (× 104/mm3) | 11.5 (3.3–189) | 14.3 (3.7–222) | 10.7 (4.9–94.3) |
PT (%) | 83 (24–112) | 86 (14–139) | 64 (37–101) |
T-Bil (mg/dL) | 0.9 (0.3–2.8) | 0.8 (0.3–2.5) | 1.6 (0.3–3.2) |
AST (IU/L) | 41 (17–568) | 50 (13–432) | 45 (16–296) |
ALT (IU/L) | 37 (11–834) | 41 (10–388) | 33 (11–204) |
Alb (g/dL) | 3.9 (2.8–5.2) | 3.8 (0.2–5.1) | 2.7 (2.0–3.5) |
ICGR15 (%) | 20 (2.6–79.2) | 16.5 (1.0–79.1) | 39.0 (6.6–76.9) |
AFP (ng/mL) | 19.8 (0.5–8390) | 34.3 (0.5–449,860) | 60.8 (0.5–25,910) |
DCP (mAU/mL) | 79.5 (10–32,365) | 345.5 (1.6–529,200) | 333.5 (10–4,673,500) |
Child-Pugh | |||
 A | 107 (87.0) | 195 (86.7) | 0 (0) |
 B | 16 (13.0) | 30 (13.3) | 30 (100.0) |
Up to seven | |||
 In | 123 (100) | – | 10 (33.3) |
 Out | – | 225 (100) | 20 (66.7) |
Tumor number | 2 (2–5) | 5 (2–20) | 3 (2–15) |
Tumor size (mm) | 35 (7–50) | 50 (8–355) | 50 (13–200) |
Treatment modalities | |||
 Resection | 70 (56.9) | 88 (39.1) | 6 (20.0) |
 TACE | 49 (39.8) | 125 (55.6) | 18 (60.0) |
 Ablation | 4 (3.0) | – | – |
 HAIC | – | 9 (4.0) | 2 (6.7) |
 Systemic chemotherapy | – | 3 (1.3) | – |
 Transplantation | – | – | 1 (0.3) |
 BSC | – | – | 3 (10.0) |